About iX Biopharma Ltd
iX Biopharma is a specialty pharmaceutical company with expertise in drug delivery systems. The company fully integrated business model, which includes drug formulation, clinical studies, regulatory affairs, manufacturing in Melbourne Australia and sales, provides significant operational benefits from lower cost of sales, enhanced operating efficiencies, better quality control, shorter time-to-market and IP protection.
iX Biopharma has developed WaferiX‚, a sublingual drug delivery platform technology. It uses WaferiX to repurpose existing drugs for new indications and new dosage forms for better efficacy and side effect profile. Leveraging WaferiX, iX Biopharma has developed a line of medicinal cannabis sublingual wafers which it supplies in Australia to patients through medical channels. Its CBD sublingual wafer, Xativa, is the winner of Australia CBD Product of the Year in 2020.